Ebola vaccines safe; but quandary for Liberia efficacy enrollment
This article was originally published in Scrip
Executive Summary
With the initial findings of an ongoing study in Liberia demonstrating that two experimental Ebola vaccines appear to be safe, scientists from the US National Institute of Allergy and Infectious Diseases (NIAID) are ready to move forward with the next phase of the trial to validate efficacy, the agency said on 26 March.